inflammation

Secukinumab Rapidly Reduces Hidden Joint Inflammation in Psoriasis Patients

by

Secukinumab, an IL-17A inhibitor, significantly reduces subclinical enthesitis in patients with moderate-to-severe plaque psoriasis, according to a study published in the journal Skin. By targeting inflammation at the attachment points of tendons and ligaments before joint pain begins, this treatment may prevent irreversible structural damage associated with psoriatic arthritis (PsA), researchers from The Second Affiliated … Read more

Neuroticism and Adversity: Key Drivers of Depression and Anxiety Risk

by

Psychosocial factors like neuroticism and life adversity contribute more to the population burden of depression and anxiety than physiological factors, according to a 13-year study in Translational Psychiatry. Using UK Biobank data, researchers found psychosocial elements account for up to 67% of the depression burden in men and 61% in women. Why do psychosocial factors … Read more

Gut Microbes Linked to Estrogen-Driven Cancers

by

Scientists are increasingly viewing gut microbes as active participants in hormone-driven cancers, moving beyond the traditional “estrobolome” model to define a bidirectional endocrine-microbiome axis. According to a review published in the journal npj Biofilms and Microbiomes, researchers are investigating how these microbial communities influence the metabolism of estrogen and contribute to the development of breast … Read more

TREM-1 Receptor: A Promising Therapeutic Target for Inflammatory Diseases

by

The Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) is emerging as a critical amplifier of the human innate immune system, according to a review published in Current Molecular Pharmacology. Researchers from Cairo University and E-JUST University identify this receptor as a potential therapeutic target for inflammatory conditions ranging from sepsis to Alzheimer’s disease, though clinical … Read more

Key Cells Driving Hypertrophic Scarring Identified

by

Researchers at the Plastic Surgery Hospital of the Chinese Academy of Medical Sciences have identified a specific fibroblast cell state—designated as “Fib_5”—that serves as a primary driver of hypertrophic scar formation. Published in Burns & Trauma in 2026, the study reveals that the transcription factor Yin Yang 1 (YY1) acts as a molecular “brake” on … Read more

Melatonin Boosts Skin Flap Survival by Fighting Ferroptosis

by

Melatonin Could Revolutionize Flap Surgery—Here’s How It Works and What’s Next Researchers have identified a new mechanism by which melatonin—already a widely used sleep supplement—could prevent tissue death in reconstructive surgeries, according to a study published in Burns & Trauma on February 2, 2026. By blocking a specific type of cell damage called ferroptosis, melatonin … Read more

New Molecular Pathway Linked to Delayed Diabetic Wound Healing

by

Researchers have identified the ILF2 protein as a critical regulator of diabetic wound healing, acting as a molecular brake that prevents the cellular senescence responsible for chronic diabetic foot ulcers (DFU). According to a study published March 17, 2026, in the journal Burns & Trauma, the loss of ILF2 leads to the accumulation of NPM1 … Read more

Prime-and-Pull Vaccine Effectively Prevents Genital Herpes

by

Researchers at the Yale School of Medicine have developed a two-part vaccination strategy that successfully prevented genital herpes infection in preclinical models. Published June 19 in Science Immunology, the study uses “prime and pull” technology—an initial intramuscular injection combined with localized nanoparticle delivery—to trigger a robust immune response at the vaginal lining, a feat traditional … Read more

Why Autoimmunity Increases With Age: The Role of Senescent Immune Cells

by

Immune aging, or immunosenescence, triggers a decline in the body’s ability to fight infections and tumors while simultaneously increasing the risk of chronic inflammation and autoimmune diseases. According to a review published in the Journal of Clinical Investigation, the human immune system reaches a critical inflection point around age 50, where molecular signatures of aging … Read more

Epigenetic Drug Boosts Blood Vessel Health by Targeting Fat

by

Researchers at the University of Zurich have identified a potential breakthrough in treating cardiometabolic disease by targeting the thin layer of fat surrounding blood vessels. According to a study published in Cell Reports, using a BET inhibitor to suppress a specific enzyme in this fat layer reduces inflammation and restores the ability of arteries to … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]